Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2)
Titel:
Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2)
Auteur:
Montalban, Xavier Vermersch, Patrick Arnold, Douglas L. Bar-Or, Amit Cree, Bruce A.C. Cross, Anne Havrdova, Eva Kubala Kappos, Ludwig Stuve, Olaf Wiendl, Heinz Wolinsky, Jerry Bolay, Claire Le Hyvert, Yann Javor, Andrija Guehring, Hans Tenenbaum, Nadia Tomic, Davorka